Evidence OSMedical evidence & research
EVIDENCE OS / RESEARCH IN PROGRESS

Medical evidence, moving forward.

FEATURED · MEDICAL EVIDENCE

When agents help people choose, what makes your product or service credible?

Explore the service and deliverables

Patient-centered personalized clinical evidence

Continuously updated evidence from global clinical research

Clinical AGI decision-making infrastructure

Portrait of Chuan Yin
Chuan YinFounder & Chief Scientist, Evidence OS
Latest CV
EOS CLINICAL AGI RESEARCH INSTITUTE

Institute · Research

Explore the Clinical AGI Institute
Research programme and evolving plans11 directions
THE RESEARCH PROGRAMME

Research directions and next steps

Each result becomes a foundation for the next study. Explore progress, next steps and research basis.

Research reportedIn progressStudy designedPlanned
Research reported

Patient-centred evidence

How should evidence be organised around patient goals and comorbidity?

A patient-centred framework manuscript organises evidence generation and use around comorbidity, patient goals and concrete questions.

Next steps & research basis
Next

Translate the framework into measurable tasks and evaluation criteria.

Research reported

Research landscape of medical LLMs

Which steps from clinical answers to living evidence have been evaluated?

A published review manuscript examines evidence across medical dialogue, retrieval, synthesis, updating and individual decisions.

Next steps & research basis
Next

Refine the programme and its evaluation requirements through continuing literature tracking.

Research reported

Social connection and surgical outcomes · Evidence compilation

Can large literature collections become reviewable, reusable evidence?

The social-connection review contains 20,399 deduplicated records and 445 studies; 72 enter at least one quantitative synthesis.

Next steps & research basis
Next

Assess reuse in comorbidity research and retain evidence that cannot be pooled.

Research reported

Reliability, governance and correction

Can each conclusion be traced to its sources, revisions and responsibilities?

An auditable system was developed and internally evaluated in one review: 50 root-cause events, 46 resolved and 4 retained limitations.

Next steps & research basis
Next

Run independent comparative evaluations of errors, costs and reviewer workload.

Study designed

Mixed-information synthesis

How much information can be retained when effect estimates are incomplete or measures and time windows differ?

Method boundaries and an evaluation design compare conventional and mixed-information synthesis for coverage and credibility.

Next steps & research basis
Next

Test additional information, statistical coherence and clinical value in the comorbidity review.

Study designed

Evidence to individual decisions

How should synthesised evidence fit decisions by patients, clinicians and institutions?

A decision-material evaluation design is established; comorbidity evidence will support further evaluation of individual applicability.

Next steps & research basis
Next

Evaluate applicability, traceability, justified abstention and decision quality; confidence alone is insufficient.

Planned

Living evidence and updates

Which conclusions should change when new studies or corrections appear?

The programme includes update triggers, versioning and correction propagation.

Next steps & research basis
Next

Define change comparisons and review triggers; evaluate delay and maintenance costs.

Planned

Evidence gaps to new studies

How can unanswered clinical questions become the next study?

The plan connects gap detection, study design and research collaboration.

Next steps & research basis
Next

Select high-value gaps from existing reviews and assess topic selection and gap closure.

Planned

Independent comparison and external validation

Can the full system improve workflow, decision quality and patient outcomes?

The plan compares human, human–AI and AI workflows in independent domains, then progresses toward hospital evaluation.

Next steps & research basis
Next

Progress through benchmarks, prospective silent testing, workflow pilots and outcome evaluation.

FRONTIERS · DAILY BRIEF

Frontiers

Understand advances in clinical AI and medical evidence, and what they mean for health choices and clinical practice.

Read daily insights
Daily selection · compiled
npj Breast Cancer | Retrospective clinical-trial data study

AI-extracted health data should remain traceable to the source

The study compared manual entry with AI extraction of breast-cancer trial data from EHRs. Each extracted variable retained a source-text location for reviewer verification.

What it means for health and care

For clinicians and research clients, source-linked results make misreadings easier to detect, disagreements easier to resolve and corrections easier to record—an important safety condition beyond efficiency.

Study limits and provenance

This was a retrospective comparison in one hospital and one cancer type. It does not establish reliable performance across hospitals, lower costs or better patient outcomes.

Artificial intelligence for clinical data extraction from EHRs in breast cancer trials: the MIRROR study
npj Artificial Intelligence | Adversarial benchmark study

Medical AI can be steered even when it cites evidence

The study shows that adding a few crafted documents to a retrieval corpus can change how medical AI frames the same facts and steer answers toward a product or viewpoint.

What it means for health and care

Patients and clinicians need more than the presence of citations: who produced the sources, whether independent sources agree, whether commercial framing is present and whether conclusions change when sources are replaced.

Study limits and provenance

This is a laboratory benchmark, not evidence that the same attack has occurred in clinical practice. Real-world frequency, patient harm and the best defence remain unproven.

FramePoison: attacks on medical RAG that target framing, not just facts
npj Digital Surgery | Scoping review

Very little published clinical evidence supports AI used during surgery

Researchers screened 3,020 records and found only five studies of real intraoperative decision support. Only one had completed results, based on five patients.

What it means for health and care

Patients, surgeons and hospitals should not treat technical demonstrations, registered trials or clinician final authority as proof of safety or benefit. Auditability, accountability and outcome evaluation remain necessary.

Study limits and provenance

The review was limited to intraoperative AI, included few heterogeneous studies, and proposed an externally unvalidated governance scorecard.

Ethical considerations for intraoperative implementation of artificial intelligence clinical decision support systems: a scoping review
METAQUANTCompare the evidence behind research investment.Research assets, ROI and trends
EVIDENCE PYRAMID

Evidence has levels. Decisions have context.

From global research to the individual patient: inspect how the evidence was produced and whether it answers the question.

A simplified guide for treatment-effect questions. Bias, consistency, precision and relevance determine confidence alongside design.

  1. Systematic reviews & meta-analyses
  2. Randomized controlled trials
  3. Observational studiesCohorts · registries · case–control
  4. Case reports & case series
  5. Expert opinion & mechanistic reasoning
Patient goalsCircumstancesIndividual relevance
Guidelines translate evidence into advice. Journal and institution names indicate provenance, not evidence quality.

Why choose Evidence OS?

CREDIBILITY

Clinical and research expertise

Clinical and research expertise combines original sources, professional review and real studies to synthesize evidence through systematic reviews and meta-analysis.

Chuan Yin · Doctorate in Clinical Medicine, Peking University; Visiting Scholar, Harvard Medical School; Founder and Chief Scientist, Evidence OS.
CREDIBILITY · RELIABILITY

Advanced mathematical and statistical methods

Develop and apply advanced mathematical and statistical models for mixed-information evidence synthesis, comorbidity research and personalized analysis. Explain assumptions, applicability and uncertainty behind method choices.

RELIABILITY

Traceable findings and processes

Provide sources, data, analyses and versions within the agreed scope. Review, corrections and updates retain an evidence trail showing how findings were formed.

RELIABILITY

Clear delivery and update commitments

Agree scope, fees, responsibilities, milestones and acceptance before engagement. Track new studies as agreed and confirm additional work and fees in advance.

INTIMACY · UNDERSTANDING

Understand concerns and respect boundaries

Listen to your goals, concerns, budget and constraints, and confirm the question together. Explain evidence in context and agree how information will be used and handled.

CLIENT INTERESTS

Assess value before committing

Present supporting, opposing and insufficient evidence honestly. Start research commissions with an assessment, then choose to proceed, narrow or pause; credit reusable work as agreed.

WORK WITH US

Tell us your question

  1. Describe your question

    Describe the purpose, inputs and timing. Scoping requests are free.

  2. Agree scope & quote

    Define deliverables, professional review, fees and acceptance.

  3. Work & deliver in stages

    Begin after contracting; agree update needs separately.

GLOBAL RESEARCH · CLINICAL CONTEXT

Multiple evidence routes. One clinical question.

Journals, evidence syntheses, registries and clinical expertise complement one another.

1 / 6

NEJM

Clinical research

Peer-reviewed studies, reviews and clinical cases. Inspect the design, population, findings and relevance of each article.

Visit original source

JAMA Network

General and specialty medicine

Clinical research, commentary and specialty journals provide traceable literature across medical questions.

Visit original source

Cochrane

Evidence synthesis

Systematic reviews combine studies around focused questions, including benefits, harms and uncertainty.

Visit original source

Expert collaboration

Clinical expertise and review

We collaborate on defined projects with individual experts from leading hospitals, including Massachusetts General Hospital, a Harvard Medical School teaching hospital, and Peking University Third Hospital. Each project identifies the contributors and their review scope.

Experts participate in their individual capacity; this does not imply an institutional partnership or endorsement.Explore expert participation

Access to public material and full text depends on permission; expert contributions and project inputs require specific authorisation. Source names and marks do not imply institutional partnerships.

Explore sources and methods